-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Sagimet Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2022 to Q1 2025.
- Sagimet Biosciences Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$14.5M, a 134% decline year-over-year.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$42.4M, a 78.6% decline from 2023.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$23.8M, a 2.96% increase from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)